Angiotech kills plan for options
Article Abstract:
Angiotech Pharmaceuticals Inc. has terminated its controversial "evergreen" stock option plan. The company came under pressure from institutional stockholders over the plan.
Publisher: Bell Globemedia Interactive
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2003
Strategy & planning, Planning, Company business planning, Angiotech Pharmaceuticals Inc.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Biovail stock sinks as rival gets FDA's okay
Article Abstract:
The impact of Food and Drug Administration's approval on Anchen Pharmaceuticals Inc.'s Wellbutrin XL, on Biovail Corp.'s stocks, is discussed.
Publisher: Bell Globemedia Interactive
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2005
Marketing procedures, Government regulation, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Antidepressant Preparations, Marketing, Licensing, certification and accreditation, Company marketing practices, Antidepressants, Biovail Corp., Wellbutrin XL (Medication)
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: Canada, Pharmaceutical industry, Securities, Company securities
Similar abstracts:
- Abstracts: Patheon shares deflate on flat forecast. Partners' dispute hits Angiotech shares. Oncolytics Biotech rises on cancer virus news
- Abstracts: Turbulence hits Transat stock. Air Canada appeals to agents. Discount line needed: Milton
- Abstracts: AT&T pressures Rogers for higher wireless bid. SEC probes trading in shares of hot Net firm
- Abstracts: Vasogen shares soar on tests of heart surgery technology. Canadian hotel stocks down sharply. Canadian Tire rolls back
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.